My Favorite Author (at least in one category)

And that category would be cancer books. I learned about Wendy Harpham from a cancer chat friend of mine, Mary. Wendy was a recurrent Non-Hodgkin's lymphoma survivor and an MD (but not an oncologist). She channeled her energy into some wonderful books on cancer - information everyone could use. The first was Diagnosis: Cancer, Your Guide to the First Months of Healthy Survivorship. Then comes When a Parent has Cancer: A Guide to Caring for your Children - a wonderful book that comes with a companion book - Becky and the Worry Cup. I ended up getting my daughters worry cups and it helped. Once I reached remission, I read After Cancer, A Guide to your New Life. It helped me understand the feelings I was having.



I discovered today she published a new book last fall - Happiness in a Storm: Facing Illness and Embracing Life as a Healthy Survivor (short titles need not apply :-). In this one, she shares here the guidelines she has developed for becoming a healthy survivor, a patient who gets good care and lives as fully as possible. This dovetails nicely with other recent books I've written about like Living with Lymphoma and The Patient from Hell.



If you like good authors, I invite you to discover Wendy Harpham.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap